Co-Authors
This is a "connection" page, showing publications co-authored by Sho Saito and Norio Ohmagari.
Connection Strength
6.599
-
Investigator initiated clinical trial of remdesivir for the treatment of COVID-19 in Japan. Glob Health Med. 2021 Apr 30; 3(2):62-66.
Score: 0.943
-
First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics. J Infect. 2021 04; 82(4):84-123.
Score: 0.911
-
Clinical Epidemiology of Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan. Clin Infect Dis. 2021 12 06; 73(11):e3677-e3689.
Score: 0.246
-
Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan. BMJ Open. 2021 06 15; 11(6):e047007.
Score: 0.238
-
How we secured a COVID-19 convalescent plasma procurement scheme in Japan. Transfusion. 2021 07; 61(7):1998-2007.
Score: 0.238
-
Clinical course of alopecia after COVID-19. Int J Infect Dis. 2021 06; 107:255-256.
Score: 0.236
-
External validation and update of prediction models for unfavorable outcomes in hospitalized patients with COVID-19 in Japan. J Infect Chemother. 2021 Jul; 27(7):1043-1050.
Score: 0.235
-
Positive Ratio of Polymerase Chain Reaction (PCR) and Validity of Pre-Screening Criteria at an Outpatient Screening Center during the Early Phase of the COVID-19 Epidemic in Japan. Jpn J Infect Dis. 2021 Sep 22; 74(5):481-486.
Score: 0.233
-
Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19. J Infect Chemother. 2021 Jun; 27(6):808-813.
Score: 0.231
-
No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity. J Infect Chemother. 2021 Apr; 27(4):653-655.
Score: 0.231
-
Telephone consults at the Infectious Disease Outpatient Clinic during the early period of the COVID-19 epidemic. Glob Health Med. 2020 Dec 31; 2(6):392-394.
Score: 0.230
-
Non-COVID-19 Patients with Life-threatening Diseases Who Visited a Fever Clinic: A Single-center, Observational Study in Tokyo, Japan. Intern Med. 2020 Dec 15; 59(24):3131-3133.
Score: 0.228
-
Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019. Open Forum Infect Dis. 2020 Nov; 7(11):ofaa507.
Score: 0.227
-
Environmental surface and air contamination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patient rooms by disease severity. Infect Prev Pract. 2020 Dec; 2(4):100098.
Score: 0.227
-
Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers. J Infect Chemother. 2021 Jan; 27(1):120-122.
Score: 0.225
-
When Clinicians Should Repeat RT-PCR for SARS-CoV-2: Repeat PCR Testing in Patients with Pulmonary CT Findings Suggestive of COVID-19. Jpn J Infect Dis. 2021 Mar 24; 74(2):161-165.
Score: 0.225
-
Possibility of transmission of severe acute respiratory syndrome coronavirus 2 in a tertiary care hospital setting: A case study. Infect Prev Pract. 2020 Sep; 2(3):100079.
Score: 0.224
-
COVID-19 can suddenly become severe: a case series from Tokyo, Japan. Glob Health Med. 2020 Jun 30; 2(3):174-177.
Score: 0.222
-
SARS-CoV-2 Screening Test for Japanese Returnees From Wuhan, China, January 2020. Open Forum Infect Dis. 2020 Jul; 7(7):ofaa243.
Score: 0.222
-
Difficulty of downscaling the precautions for coronavirus disease-19 based on negative throat polymerase chain results in the early phase of infection. J Infect Chemother. 2020 Aug; 26(8):851-853.
Score: 0.220
-
Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospital. Psychiatry Res. 2020 07; 289:113040.
Score: 0.220
-
Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospital. Psychiatry Res. 2020 Apr 29; 289:113040.
Score: 0.220
-
Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19. Gene. 2021 Jan 15; 766:145145.
Score: 0.056
-
Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers. Crit Care Explor. 2020 Aug; 2(8):e0170.
Score: 0.056
-
SARS-CoV-2 infection among returnees on charter flights to Japan from Hubei, China: a report from National Center for Global Health and Medicine. Glob Health Med. 2020 Apr 30; 2(2):107-111.
Score: 0.055